FI990991L - Menetelmä irreversiibeleille neurovahingoille riskialttiin yksikön identifioimiseksi - Google Patents

Menetelmä irreversiibeleille neurovahingoille riskialttiin yksikön identifioimiseksi Download PDF

Info

Publication number
FI990991L
FI990991L FI990991A FI990991A FI990991L FI 990991 L FI990991 L FI 990991L FI 990991 A FI990991 A FI 990991A FI 990991 A FI990991 A FI 990991A FI 990991 L FI990991 L FI 990991L
Authority
FI
Finland
Prior art keywords
identifying
risk
unit
neurological damage
irreversible neurological
Prior art date
Application number
FI990991A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI990991A7 (fi
FI990991A0 (fi
Inventor
Pentti Sipponen
Matti Haerkoenen
Osmo Suovaniemi
Erik Forsblom
Original Assignee
Locus Genex Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Locus Genex Oy filed Critical Locus Genex Oy
Priority to FI990991A priority Critical patent/FI990991L/fi
Publication of FI990991A0 publication Critical patent/FI990991A0/fi
Priority to PCT/FI2000/000376 priority patent/WO2000067029A1/en
Priority to EP00922683A priority patent/EP1173764B1/en
Priority to ES00922683T priority patent/ES2258453T3/es
Priority to DK00922683T priority patent/DK1173764T3/da
Priority to RU2001132334/15A priority patent/RU2224258C2/ru
Priority to CN00808519A priority patent/CN1353816A/zh
Priority to PT00922683T priority patent/PT1173764E/pt
Priority to DE60026285T priority patent/DE60026285T2/de
Priority to AU42997/00A priority patent/AU4299700A/en
Priority to AT00922683T priority patent/ATE319088T1/de
Priority to JP2000615816A priority patent/JP2002543430A/ja
Publication of FI990991A7 publication Critical patent/FI990991A7/fi
Publication of FI990991L publication Critical patent/FI990991L/fi

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/82—Translation products from oncogenes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96472—Aspartic endopeptidases (3.4.23)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Electrotherapy Devices (AREA)
FI990991A 1999-04-30 1999-04-30 Menetelmä irreversiibeleille neurovahingoille riskialttiin yksikön identifioimiseksi FI990991L (fi)

Priority Applications (12)

Application Number Priority Date Filing Date Title
FI990991A FI990991L (fi) 1999-04-30 1999-04-30 Menetelmä irreversiibeleille neurovahingoille riskialttiin yksikön identifioimiseksi
JP2000615816A JP2002543430A (ja) 1999-04-30 2000-04-28 ペプシノーゲンｉ（ｐｇｉ）及びビタミンｂ１２の濃度を定量的に測定するステップを含む、不可逆的な神経障害の危険性のある人を同定する方法
CN00808519A CN1353816A (zh) 1999-04-30 2000-04-28 不可逆性神经损伤易感个体的鉴定方法,包括定量检测胃蛋白酶原i(pgi)和维生素b12浓度的步骤
EP00922683A EP1173764B1 (en) 1999-04-30 2000-04-28 Method for identifying an individual at risk for irreversible neurodamages, comprising the steps of determining quantitatively the concentration of pepsinogen i (pgi) and vitamin b12
ES00922683T ES2258453T3 (es) 1999-04-30 2000-04-28 Metodo para identificar un individuo con riesgo de daños neurologicos irreversibles, que comprende las etapas de determinacion cuantitativa de la concentracion de pepsinogeno (i) y vitamina b12.
DK00922683T DK1173764T3 (da) 1999-04-30 2000-04-28 Fremgangsmåde til identifikation af et individ med risiko for irreversible neuroskader, omfattende trinnene kvantitativ bestemmelse af koncentrationen af pepsinogen I (PGI) og vitamin B12
RU2001132334/15A RU2224258C2 (ru) 1999-04-30 2000-04-28 Способ идентификации индивидуума, у которого существует риск необратимых неврологических повреждений, включающий в себя этапы количественного определения концентрации пепсиногена i (pgi) и витамина в12
PCT/FI2000/000376 WO2000067029A1 (en) 1999-04-30 2000-04-28 Method for identifying an individual at risk for irreversible neurodamages, comprising the steps of determining quantitatively the concentration of pepsinogen i (pgi) and vitamin b12
PT00922683T PT1173764E (pt) 1999-04-30 2000-04-28 Metodo para identificar um individuo em perigo de danos neurologicos irreversiveis, compreendendo os passos de determinar quantitativamente a concentracao de pepsinogenio i (pgi) e vitamina b12
DE60026285T DE60026285T2 (de) 1999-04-30 2000-04-28 Verfahren zur abschätzung des individuellen risikos einer irreversiblen nervenschädigung, das schritte zur quantitativen bestimmung der pepsinogen-i (pgi) und vitamin b12 konzentrationen umfasst
AU42997/00A AU4299700A (en) 1999-04-30 2000-04-28 Method for identifying an individual at risk for irreversible neurodamages, comprising the steps of determining quantitatively the concentration of pepsinogen i(pgi) and vitamin b12
AT00922683T ATE319088T1 (de) 1999-04-30 2000-04-28 Verfahren zur abschätzung des individuellen risikos einer irreversiblen nervenschädigung, das schritte zur quantitativen bestimmung der pepsinogen-i (pgi) und vitamin b12 konzentrationen umfasst

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI990991A FI990991L (fi) 1999-04-30 1999-04-30 Menetelmä irreversiibeleille neurovahingoille riskialttiin yksikön identifioimiseksi

Publications (3)

Publication Number Publication Date
FI990991A0 FI990991A0 (fi) 1999-04-30
FI990991A7 FI990991A7 (fi) 2000-10-31
FI990991L true FI990991L (fi) 2000-10-31

Family

ID=8554566

Family Applications (1)

Application Number Title Priority Date Filing Date
FI990991A FI990991L (fi) 1999-04-30 1999-04-30 Menetelmä irreversiibeleille neurovahingoille riskialttiin yksikön identifioimiseksi

Country Status (12)

Country Link
EP (1) EP1173764B1 (enExample)
JP (1) JP2002543430A (enExample)
CN (1) CN1353816A (enExample)
AT (1) ATE319088T1 (enExample)
AU (1) AU4299700A (enExample)
DE (1) DE60026285T2 (enExample)
DK (1) DK1173764T3 (enExample)
ES (1) ES2258453T3 (enExample)
FI (1) FI990991L (enExample)
PT (1) PT1173764E (enExample)
RU (1) RU2224258C2 (enExample)
WO (1) WO2000067029A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20010019L (fi) * 2001-01-05 2002-07-06 Biohit Oyj Menetelmä atrofisen diagnostisoimiseksi
FI20065542A0 (fi) * 2006-09-01 2006-09-01 Biohit Oyj Menetelmä ja näytteenottopakkaus vatsan limakalvon tilan arvioimiseksi
RU2413940C2 (ru) * 2009-02-02 2011-03-10 Государственное образовательное учреждение высшего профессионального образования Воронежская государственная технологическая академия Способ определения витамина b12 в водных растворах

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI97304C (fi) * 1994-11-16 1996-11-25 Locus Genex Oy Menetelmä mahasyövän riskin seulonnaksi

Also Published As

Publication number Publication date
JP2002543430A (ja) 2002-12-17
ATE319088T1 (de) 2006-03-15
FI990991A7 (fi) 2000-10-31
PT1173764E (pt) 2006-06-30
DE60026285T2 (de) 2006-11-09
CN1353816A (zh) 2002-06-12
WO2000067029A1 (en) 2000-11-09
DE60026285D1 (de) 2006-04-27
AU4299700A (en) 2000-11-17
FI990991A0 (fi) 1999-04-30
EP1173764A1 (en) 2002-01-23
RU2224258C2 (ru) 2004-02-20
ES2258453T3 (es) 2006-09-01
DK1173764T3 (da) 2006-05-08
EP1173764B1 (en) 2006-03-01

Similar Documents

Publication Publication Date Title
FI990323A7 (fi) Menetelmä tiedon turvaamiseksi
DE59907870D1 (de) Fangeinrichtung für ein steigschutzsystem
DE60045213D1 (de) Herstellungverfahren und -vorrichtung für ein hologramm
IL131242A0 (en) A method for temperature sensing
NO20021988L (no) Overvåkningssystem for avleiringer
NO20002585L (no) Fremgangsmåte for komplettering av en brönn
FI972039A7 (fi) Menetelmä pakettivälitteiseen tiedonsiirtoon
FI972041A7 (fi) Menetelmä pakettivälitteiseen tiedonsiirtoon
DE60010484D1 (de) Wärmeleitende vorrichtung für eine leiterplatte
ATE279856T1 (de) Marke für tiere
DE69932635D1 (de) Hocheffiziente spannungsversorgung fuer eine zweidrahtschleifengespeisste vorrichtung
DE60030902D1 (de) Vorrichtung zum Datenempfang
FI972040A7 (fi) Menetelmä pakettivälitteiseen tiedonsiirtoon
DE60009138D1 (de) Vorrichtung zum einwickeln einer spule
FI19992329L (fi) Menetelmä tiedonsiirtoyhteyden ylläpitämiseksi
DE69821641D1 (de) Herstellungsverfahren für knochenverbindungsvorrichtung
FI19992315L (fi) Menetelmä hillon valmistamiseksi
IT1311739B1 (it) Apparecchio di bobina a connettore integrato
FI19992761L (fi) Menetelmä kuljetusvälineen kunnon valvomiseksi
FI990991A7 (fi) Menetelmä irreversiibeleille neurovahingoille riskialttiin yksikön identifioimiseksi
FI972108A7 (fi) Menetelmä parametrien siirtämiseksi
FI981260A7 (fi) Menetelmä puhelun yksilöimiseksi
FI990936A0 (fi) Menetelmä datan tarkastamiseksi
FI19992786A7 (fi) Menetelmä ohjelmamoduulin lataamiseksi
FI982556A0 (fi) Sijainnin hallintamenetelmä